Citrini backs life sciences stocks after Claude protein tests

First reported by Bloomberg at · Updated · 2 sources

According to Quartz, the firm used Claude to design 211 proteins for laboratory testing, with 17 found to bind to scorpion toxins; whether they block those toxins remains untested. Bloomberg reports that Citrini sees life sciences companies benefiting from AI-driven drug discovery after testing Anthropic's Claude Science.

Covered by 2 publishers within 1 hour of the first report.

Reporting2

Bloomberg Citrini Bets on Life Sciences After Claude AI Drug Study · Georgie McKay and Angel Adegbesan
Quartz Citrini Research is backing life sciences stocks after using Claude to design proteins · Cris Tolomia

Related

Anthropic adds dashboards and animation tools to Claude
Zillow adds a connector to bring home searches into Claude
Oblivion Remastered fan uses Claude to create performance patch
MIT researchers observe Claude agents playing on a virtual island

Topics Anthropic